SMTL ID : 4cby.2 (3 other biounits)

Design, synthesis, and biological evaluation of potent and selective Class IIa HDAC inhibitors as a potential therapy for Huntington's disease

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.72 Å

Oligo State

monomer

Ligands

1 x KEE: (1R,2R,3R)-2-[4-(1,3-oxazol-5-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide(Non-covalent)

KEE.1: 12 residues within 4Å: Chain A: P.32, E.33, R.37, H.158, H.159, F.168, D.196, H.198, F.227, D.290, G.330 Ligands: ZN.2 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:P.32, A:E.33, A:F.168 Hydrogen bonds: A:G.330 Water bridges: A:G.331 pi-Stacking: A:F.227

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: D.196, H.198, D.290 Ligands: KEE.1 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:D.196, A:D.196, A:H.198, A:D.290 ZN.3: 4 residues within 4Å: Chain A: C.23, C.25, H.31, C.107 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.23, A:C.25, A:H.31, A:C.107

2 x NA: SODIUM ION(Non-functional Binders)

NA.4: 6 residues within 4Å: Chain A: D.194, W.195, D.196, H.198, S.217, L.218 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.217, A:L.218 NA.5: 4 residues within 4Å: Chain A: F.207, D.210, V.213, F.244 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.210, A:D.210 Water bridges: A:Y.215

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Burli, R.W. et al., Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease. J. Med. Chem. (2013)

Release Date

2013-12-11

Peptides

HISTONE DEACETYLASE 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

HISTONE DEACETYLASE 4

Related Entries With Identical Sequence